Pneumonia Vaccine Research for Babies

Trusted Pediatric Researchers Enrolling a Ph. 3 Pneumonia Vaccine Study

Helios Clinical Research is conducting a clinical study on an investigational pneumococcal vaccine for infants. If your child is between 42 and 89 days (~3 months) of age, they could be eligible to participate.

First Name * Required

Last Name * Required

Email * Required

Zip Code * Required

Phone (10 digits) Please enter 10 digits for phone number. Required when opting in to SMS.

I consent to Helios contacting me about this clinical trial via email as described within the Helios privacy policy. You must consent to the privacy policy.

I opt in to receive SMS messages regarding currently enrolling studies and other helpful research-related information from Helios Clinical Research. Message frequency varies. Text HELP to 34246 or email recruitmentteam@heliosclinical.com for help. Text STOP to 34246 to end. Msg & Data Rates May Apply. By opting in, I authorize Helios Clinical Research to deliver marketing messages using an automatic telephone dialing system, and I understand that I am not required to opt in as a condition of purchasing any property, goods, or services. Click to view Terms and Conditions and Privacy Policy. If you consent to SMS messages, you must provide a phone number.

Purpose of the Study

Helios Clinical Research is conducting a clinical study on a phase 3, investigational, 21-Valent pneumococcal vaccine for infants. The purpose of this study is to measure whether the investigational pneumococcal vaccine is safe and can help the body develop antibodies when compared to the standard of care 20-valent pneumococcal vaccine.

Study Requirements

Your child may qualify if:

They are between 42 to 89 days (about 3 months) of age

Potential Benefits of Participation

Access to new treatments that are
not yet available to the general public.

Personalized medical attention from leading healthcare professionals.

Compensation provided to qualified participants

Study Locations

This study is currently enrolling at the following sites:

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.